Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Youyou Hu"'
Autor:
Chiun Hsu, Michel Ducreux, Andrew X. Zhu, Shukui Qin, Masafumi Ikeda, Tae-You Kim, Peter R. Galle, Richard S. Finn, Ethan Chen, Ning Ma, Youyou Hu, Lindong Li, Ann-Lii Cheng
Publikováno v:
Liver Cancer (2022)
Introduction: In the Phase 3 IMbrave150 trial (NCT03434379), atezolizumab + bevacizumab demonstrated a clinically meaningful survival benefit over sorafenib in patients with unresectable hepatocellular carcinoma (HCC), including those with hepatitis
Externí odkaz:
https://doaj.org/article/b9a0faf9c9a043ee9b76567a5b82f791